IL6 and depressive disorder: We hypothesized that genetically predicted increased IL-6 and IL-6R activity would be associated with reduced gray matter volume and cortical thickness (CT) in areas highly relevant to neuropsychiatric disorders, including schizophrenia, autism spectrum disorder, and depression.